Article
A hybrid implementation-effectiveness randomized trial of CYP2D6-guided postoperative pain management.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Apr 2021
Thomas Cameron D, Parvataneni Hari K, Gray Chancellor F, Deen Justin T, Prieto Hernan A, Pulido Luis F, Elsey Amanda R, Elwood Erica N, Starostik Petr, Gong Yan, Fillingim Roger B, Johnson Julie A, Cavallari Larisa H
Abstract excerpt
PURPOSE: Cytochrome P450 2D6 (CYP2D6) genotype-guided opioid prescribing is limited. The purpose of this type 2 hybrid implementation-effectiveness trial was to evaluate the feasibility of clinically implementing CYP2D6-guided postsurgical pain management and determine that such an approach did not worsen pain control. METHODS: Adults undergoing total joint arthroplasty were randomized 2:1 to genotype-guided or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
